Evidence map›Paper›PMID 30021927›Full record

ArticleJournal of the Royal Society, Interface2018

A reversible fluorescent probe for monitoring Ag(I) ions.

Zelong Lim, David G Smith, Jacek L Kolanowski, Rebecca L Mattison, Jonathan C Knowles, Song-Yi Baek, Wojciech Chrzanowski, Elizabeth J New

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the Royal Society, Interface, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. A new bio-compatible CdRSC advances · 2020
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Zelong LimSchool of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia.
David G SmithSchool of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia.
Jacek L KolanowskiSchool of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia.
Rebecca L MattisonSchool of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia.
Jonathan C KnowlesDivision of Biomaterials and Tissue Engineering, University College London Eastman Dental Institute, London WC1X 8LD, UK.
Song-Yi BaekDivision of Biomaterials and Tissue Engineering, University College London Eastman Dental Institute, London WC1X 8LD, UK.
Wojciech ChrzanowskiThe University of Sydney School of Pharmacy, Sydney, New South Wales 2006, Australia wojciech.chrzanowski@sydney.edu.au.
Elizabeth J NewSchool of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia elizabeth.new@sydney.edu.au.ORCID 0000-0002-2310-254X
The University of Sydney · AUEastman Dental Hospital · GBMRC Centre for Regenerative Medicine · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver-containing nanomaterials are of interest for their antibiotic properties, for a wide range of applications from medicine to consumer products. However, much remains to be learnt about the degradation of such materials and their effects on human health. While most analyses involve measurement of total silver levels, it is important also to be able to measure concentrations of active free Ag(I) ions. We report here the preparation of a coumarin-based probe, thiocoumarin silver sensor 1 (

Indexed as

BacteriaCandida albicansCoumarinsFluorescent DyesMetal NanoparticlesSilverSpectrometry, FluorescenceCoumarinsFluorescent DyesSilverantibacterialfluorescent probephosphate glasssilver

Identifiers

PMID30021927
PMCPMC6073652
OpenAlexW2884029539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.